G0800247/Medical Research Council/United Kingdom[Grant Number] - Search Results

Year	Number of Results
2008	1
2009	8
2010	7
2011	12
2012	12
2013	18
2014	14
2015	23
2016	9
2017	5
2021	0

1

Special issue of BJP on nanomedicine.

Owen A. Owen A. Br J Pharmacol. 2014 Sep;171(17):3961-2. doi: 10.1111/bph.12820. Br J Pharmacol. 2014. PMID: 25113563 Free PMC article.

2

New approaches to antiretroviral drug delivery: challenges and opportunities associated with the use of long-acting injectable agents.

Boffito M, Jackson A, Owen A, Becker S. Boffito M, et al. Drugs. 2014 Jan;74(1):7-13. doi: 10.1007/s40265-013-0163-7. Drugs. 2014. PMID: 24327298 Review.

3

Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.

Tatham LM, Rannard SP, Owen A. Tatham LM, et al. Ther Deliv. 2015;6(4):469-90. doi: 10.4155/tde.15.4. Ther Deliv. 2015. PMID: 25996045 Review.

4

The role of drug transporters in the kidney: lessons from tenofovir.

Moss DM, Neary M, Owen A. Moss DM, et al. Front Pharmacol. 2014 Nov 11;5:248. doi: 10.3389/fphar.2014.00248. eCollection 2014. Front Pharmacol. 2014. PMID: 25426075 Free PMC article. Review.

5

Nanomedicines for HIV therapy.

Siccardi M, Martin P, McDonald TO, Liptrott NJ, Giardiello M, Rannard S, Owen A. Siccardi M, et al. Ther Deliv. 2013 Feb;4(2):153-6. doi: 10.4155/tde.12.156. Ther Deliv. 2013. PMID: 23343155

6

The application of nanotechnology in medicine: treatment and diagnostics.

Owen A, Dufès C, Moscatelli D, Mayes E, Lovell JF, Katti KV, Sokolov K, Mazza M, Fontaine O, Rannard S, Stone V. Owen A, et al. Nanomedicine (Lond). 2014 Jul;9(9):1291-4. doi: 10.2217/nnm.14.93. Nanomedicine (Lond). 2014. PMID: 25204820 Free article.

7

Special populations and pharmacogenetic issues in tuberculosis drug development and clinical research.

McIlleron H, Abdel-Rahman S, Dave JA, Blockman M, Owen A. McIlleron H, et al. J Infect Dis. 2015 Jun 15;211 Suppl 3(Suppl 3):S115-25. doi: 10.1093/infdis/jiu600. J Infect Dis. 2015. PMID: 26009615 Free PMC article. Review.

8

Interaction of Rifampin and Darunavir-Ritonavir or Darunavir-Cobicistat In Vitro.

Roberts O, Khoo S, Owen A, Siccardi M. Roberts O, et al. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e01776-16. doi: 10.1128/AAC.01776-16. Print 2017 May. Antimicrob Agents Chemother. 2017. PMID: 28193650 Free PMC article.

9

Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment.

Nelson AG, Zhang X, Ganapathi U, Szekely Z, Flexner CW, Owen A, Sinko PJ. Nelson AG, et al. J Control Release. 2015 Dec 10;219:669-680. doi: 10.1016/j.jconrel.2015.08.042. Epub 2015 Aug 24. J Control Release. 2015. PMID: 26315816 Free PMC article. Review.

10

Emerging nanomedicine applications and manufacturing: progress and challenges.

Sartain F, Greco F, Hill K, Rannard S, Owen A. Sartain F, et al. Nanomedicine (Lond). 2016 Mar;11(6):577-80. doi: 10.2217/nnm.16.17. Epub 2016 Feb 25. Nanomedicine (Lond). 2016. PMID: 26911307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results